TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds February 29, 2008
TCL Archive NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection December 4, 1998
TCL Archive NCI, Advisors Concur On Need For New Mechanism To Include Cancer Control, Minority Center Needs September 21, 1984